Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies

BACKGROUND: Long-term treatment with antipsychotic agents is indicated for patients with schizophrenia, but treatment is associated with adverse events (AEs) that contribute to medication discontinuation and nonadherence. Understanding drug safety profiles is critical to avoid unwanted side effects....

Descripción completa

Detalles Bibliográficos
Autores principales: Barabássy, Ágota, Sebe, Barbara, Acsai, Károly, Laszlovszky, István, Szatmári, Balázs, Earley, Willie R, Németh, György
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040316/
https://www.ncbi.nlm.nih.gov/pubmed/33854317
http://dx.doi.org/10.2147/NDT.S301225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040316/
https://www.ncbi.nlm.nih.gov/pubmed/33854317
http://dx.doi.org/10.2147/NDT.S301225

Ejemplares similares